Asthma Intervention With Residential Ventilation and Air Cleaner (AIRVAC) Study
Energy Recovery Ventilation and Air Cleaner Interventions to Improve Indoor Air Quality, Mold Control, and Asthma-Related Health Outcomes Among Inner-City Children and Adults in Low-Income Households
2 other identifiers
interventional
80
1 country
2
Brief Summary
The primary goal of this study is to investigate the comparative long-term (i.e., 1-year) effectiveness of energy recovery ventilators (ERVs) and portable air cleaners (PACs) in reducing indoor air pollutants and mold levels and improving asthma-related health outcomes in inner-city children and adults with asthma in low-income households in the Dallas-Fort Worth (DFW) metropolitan area, TX. Secondary goals include: (1) examining associations among asthma outcomes, exposure to indoor air pollutants and mold, and housing-related factors, (2) conducting a cost-benefit analysis of ERV and PAC interventions for improving IAQ, mold control, and health outcomes, and (3) evaluating the utility of cost-effective methods and protocols for measuring IAQ and mold for indoor air pollution epidemiology studies and for providing practical information to patients and their physicians. Using a double-blind, placebo-controlled randomized controlled trial, 80 households will be assigned to receive active or placebo versions of ERVs or PACs. Environmental exposures and housing conditions will be monitored alongside comprehensive health assessments, including lung function tests and validated surveys on asthma control, quality of life, stress, and sleep quality.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2025
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 2, 2025
CompletedFirst Posted
Study publicly available on registry
September 29, 2025
CompletedStudy Start
First participant enrolled
October 10, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 28, 2028
October 29, 2025
October 1, 2025
2.3 years
September 2, 2025
October 27, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Pulmonary Function (Spirometry)
Pulmonary function will be assessed using an EasyOne Air spirometer. The primary parameters measured include Forced Expiratory Volume in 1 second (FEV₁), Forced Vital Capacity (FVC), and the FEV₁/FVC ratio.
Baseline; 6 months; 18 months; 24 months
Asthma Control Test Score
Asthma Control Test (ACT) for adults and Childhood Asthma Control Test (C-ACT) for children every month throughout the 2-year study. ACT score range: 5-25; higher scores indicate better asthma control. C-ACT score range: 0-27; higher scores indicate better asthma control.
From enrollment to the end of intervention at 1 month (24 months in total)
Secondary Outcomes (4)
Asthma-Related Quality Of Life (Adults)
Baseline; 6 months; 18 months; 24 months
Asthma-Related Quality Of Life (Children)
Baseline; 6 months; 18 months; 24 months
Stress Levels
Baseline; 6 months; 18 months; 24 months
Sleep Quality
Baseline; 6 months; 18 months; 24 months
Study Arms (4)
Active ERV
ACTIVE COMPARATORA group that will receive an active energy recovery ventilator for 1 year
Sham ERV
SHAM COMPARATORA group that will receive a sham energy recovery ventilator (recirculation mode only) for 1 year
Active PAC
ACTIVE COMPARATORA group that will receive an active portable air cleaner for 1 year
Sham PAC
SHAM COMPARATORA group that will receive a sham portable air cleaner (HEPA filter removed) for 1 year
Interventions
A mechanical ventilation system that exchanges stale indoor air with fresh outdoor air while transferring heat and moisture between the incoming and outgoing air streams
A standalone home device that filters indoor air to remove particulate matter, allergens, and other pollutants
A home-installed ERV unit that operates in recirculation mode only, providing no fresh air exchange or heat/moisture transfer, serving as a placebo for study purposes.
A portable air cleaner that appears to operate like an active unit but does not contain a HEPA filter and does not clean the air, serving as a placebo for study purposes
Eligibility Criteria
You may qualify if:
- Individuals with physician-diagnosed asthma, including both adults and children aged 5-17
- Homeowners living in the DFW metropolitan area, TX
You may not qualify if:
- Participants living in homes with any smokers
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
University of Texas at Arlington
Arlington, Texas, 76010, United States
Rebuilding Together North Texas
Plano, Texas, 75025, United States
Related Publications (3)
Bolen RM, Lamb JL. Guardian support of sexually abused children: a study of its predictors. Child Maltreat. 2002 Aug;7(3):265-76. doi: 10.1177/1077559502007003008.
PMID: 12139193BACKGROUNDKang I, McCreery A, Azimi P, Gramigna A, Baca G, Hayes W, Crowder T, Scheu R, Evens A, Stephens B. Impacts of residential indoor air quality and environmental risk factors on adult asthma-related health outcomes in Chicago, IL. J Expo Sci Environ Epidemiol. 2023 May;33(3):358-367. doi: 10.1038/s41370-022-00503-z. Epub 2022 Nov 30.
PMID: 36450925BACKGROUNDKang I, McCreery A, Azimi P, Gramigna A, Baca G, Abromitis K, Wang M, Zeng Y, Scheu R, Crowder T, Evens A, Stephens B. Indoor air quality impacts of residential mechanical ventilation system retrofits in existing homes in Chicago, IL. Sci Total Environ. 2022 Jan 15;804:150129. doi: 10.1016/j.scitotenv.2021.150129. Epub 2021 Sep 8.
PMID: 34798726BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Insung Kang, Ph.D.
The University of Texas at Arlington
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
September 2, 2025
First Posted
September 29, 2025
Study Start
October 10, 2025
Primary Completion (Estimated)
January 31, 2028
Study Completion (Estimated)
February 28, 2028
Last Updated
October 29, 2025
Record last verified: 2025-10
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared due to privacy and confidentiality concerns for participants and because the consent forms do not include provisions for public data sharing